Xap Therapeutics Limited

Active10613866 Private limited company
Incorporated
10 February 2017 (9 years)
Previously known as
Rockend Limited (until 20 July 2021)
This list may be incomplete. See all names on Companies House
Industry
Activities of venture and development capital companies (64303)
Accounts type
Group
Region
East of England
Address
Babraham Research Campus
Maia Building (B270)
Cambridge
CB22 3AT

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
23 February 2027
Last conf. stmt
9 February 2026

Charges

Total
3
Outstanding
2
Part satisfied
0
Satisfied
1

Officers 5 active

Officer details are public data from the Companies House register.

Director · Appointed 6 August 2025
British
Born July 1984 (42)
Stevens, Josephine Angela
Secretary · Appointed 19 July 2022
Director · Appointed 27 April 2020
German
Born June 1967 (59)
Director · Appointed 5 September 2017
British,American
Born March 1977 (49)
Director · Appointed 10 February 2017
Canadian
Born February 1970 (56)
Officer history (3 former)
6 August 2025
Appointed Kudari, Mahesh as Director
6 August 2025
Resigned Foy, Matthew as Director
14 December 2023
Resigned Goldsmith, Bruce as Director
27 April 2023
Appointed Goldsmith, Bruce as Director
19 July 2022
Appointed Stevens, Josephine Angela as Secretary
19 July 2022
Resigned Oakwood Corporate Secretary Limited as Corporate Secretary
29 July 2020
Appointed Oakwood Corporate Secretary Limited as Corporate Secretary
27 April 2020
Appointed Novak, Rodger, Dr as Director
5 September 2017
Appointed George, Simeon John as Director
5 September 2017
Appointed Foy, Matthew as Director
10 February 2017
Appointed Foy, Shaun Patrick as Director

Ownership 0 active

People and entities with significant control, from the Companies House PSC register

The company has declared that it has no person with significant control.
Former controllers (3)
19 April 2021
Ceased Rodger Novak — Owns 25–50% of shares
19 April 2021
Ceased Shaun Patrick Foy — Owns 25–50% of shares
17 September 2020
Ceased Glaxosmithkline Finance PLC — Owns 25–50% of shares

Financials

Net Assets
(£206,248)
down £98,996 (92%)
Cash
£204,764
up £21,164 (12%)
Current Ratio
3.9x
Balance sheet detail
2019
Current Assets£232,841
Debtors£28,077
Cash£204,764
Creditors (< 1 year)£59,870
Creditors (> 1 year)£379,219
Net Current Assets£172,971
Net Assets(£206,248)
Shareholder Funds(£206,248)

Filings

Recent filings only. See the full history on Companies House

Show all recent filings

Some other companies at this address

Other companies in this industry

By trade and location

New companies in Cambridge →

Explore the largest companies

Largest companies in Cambridge, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?